Evidence map›Paper›PMID 36257965›Full record

ArticleNature communications2022

The hypoxia response pathway promotes PEP carboxykinase and gluconeogenesis in C. elegans.

Mehul Vora, Stephanie M Pyonteck, Tatiana Popovitchenko, Tarmie L Matlack, Aparna Prashar, Nanci S Kane, John Favate, Premal Shah, Christopher Rongo

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. OSM-11 modulates salinity-stress tolerance inbioRxiv : the preprint server for biology · 2025
    Article
  9. TheInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. The Hypoglycemic Activity ofGels (Basel, Switzerland) · 2025
    Article
  12. Suppressing APOE4-induced neural pathologies by targeting the VHL-HIF axis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Genome-wide analysis of Smad and Schnurri transcription factors inbioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Suppressing APOE4-induced mortality and cellular damage by targeting VHL.bioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mehul VoraThe Waksman Institute, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA.
Stephanie M PyonteckThe Waksman Institute, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA.
Tatiana PopovitchenkoThe Waksman Institute, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA.
Tarmie L MatlackThe Waksman Institute, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA.
Aparna PrasharThe Department of Genetics, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA.
Nanci S KaneThe Waksman Institute, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA.
John FavateThe Department of Genetics, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA.ORCID http://orcid.org/0000-0001-6344-4854
Premal ShahThe Department of Genetics, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA.ORCID http://orcid.org/0000-0002-8424-4218
Christopher RongoThe Waksman Institute, Rutgers The State University of New Jersey, Piscataway, NJ, 08854, USA. crongo@waksman.rutgers.edu.ORCID http://orcid.org/0000-0002-1361-5288
Rutgers, The State University of New Jersey · US

Funding

Genetics Analysis of Neuronal Hypoxic Stress ResistanceR01GM101972 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI RONGO, CHRISTOPHER G · 2012 to 2024
$4.1M
Dynamics and evolution of translational regulationR35GM124976 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI SHAH, PREMAL R · 2017 to 2021
$1.9M
Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) R01GM101972NIGMS NIH HHS R01 GM101972NIGMS NIH HHS R35 GM124976
6 · The paper itself

Abstract

Actively dividing cells, including some cancers, rely on aerobic glycolysis rather than oxidative phosphorylation to generate energy, a phenomenon termed the Warburg effect. Constitutive activation of the Hypoxia Inducible Factor (HIF-1), a transcription factor known for mediating an adaptive response to oxygen deprivation (hypoxia), is a hallmark of the Warburg effect. HIF-1 is thought to promote glycolysis and suppress oxidative phosphorylation. Here, we instead show that HIF-1 can promote gluconeogenesis. Using a multiomics approach, we reveal the genomic, transcriptomic, and metabolomic landscapes regulated by constitutively active HIF-1 in C. elegans. We use RNA-seq and ChIP-seq under aerobic conditions to analyze mutants lacking EGL-9, a key negative regulator of HIF-1. We integrate these approaches to identify over two hundred genes directly and functionally upregulated by HIF-1, including the PEP carboxykinase PCK-1, a rate-limiting mediator of gluconeogenesis. This activation of PCK-1 by HIF-1 promotes survival in response to both oxidative and hypoxic stress. Our work identifies functional direct targets of HIF-1 in vivo, comprehensively describing the metabolome induced by HIF-1 activation in an organism.

Indexed as

Caenorhabditis elegansGluconeogenesisAnimalsCell HypoxiaHypoxiaHypoxia-Inducible Factor 1, alpha SubunitOxygenTranscription FactorsHypoxia-Inducible Factor 1, alpha SubunitOxygenTranscription Factors

Identifiers

PMID36257965
PMCPMC9579151
OpenAlexW4306734808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.